NASDAQ: CTXR
Citius Pharmaceuticals Inc Stock Ownership - Who owns Citius Pharmaceuticals?

Insider buying vs selling

Have Citius Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CTXR insiders and whales buy or sell their stock.

CTXR Shareholders

What type of owners hold Citius Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leonard L. Mazur119.34%10,255,343$7.81MInsider
Myron Z. Holubiak23.18%1,992,243$1.52MInsider
Vanguard Group Inc3.00%257,631$196.31kInstitution
Geode Capital Management LLC0.89%76,506$58.30kInstitution
Blackrock Inc0.84%72,227$55.04kInstitution
Jaime Bartushak0.70%60,353$45.99kInsider
Squarepoint Ops LLC0.58%49,668$37.85kInstitution
Ifp Advisors Inc0.47%40,416$30.80kInstitution
Osaic Holdings Inc0.47%40,283$30.70kInstitution
Millennium Management LLC0.38%32,320$24.63kInstitution

1 of 3

CTXR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTXR5.22%94.78%
MTVA3.18%96.82%Net BuyingNet Selling
INDP4.42%50.94%Net Buying
LIPO0.53%69.70%Net Buying
SNGX0.03%99.97%

Citius Pharmaceuticals Stock Ownership FAQ

Who owns Citius Pharmaceuticals?

Citius Pharmaceuticals (NASDAQ: CTXR) is owned by 7.89% institutional shareholders, 143.39% Citius Pharmaceuticals insiders, and 0.00% retail investors. Leonard L. Mazur is the largest individual Citius Pharmaceuticals shareholder, owning 10.26M shares representing 119.34% of the company. Leonard L. Mazur's Citius Pharmaceuticals shares are currently valued at $7.85M.

If you're new to stock investing, here's how to buy Citius Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.